Dr. Henry Huffman, MD
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 499
Licensed in Texas since 1998, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: University of Mississippi School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
TX license K6607 (first issued 1998; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Waco Gastroenterology Associates (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 499
- Services billed
- 1,672
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 531 | 296 |
| Special stained specimen slides to examine tissue, each additional procedure | 268 | 75 |
| Pathology examination of tissue using a microscope, moderately high complexity | 123 | 97 |
| Special stained specimen slides to examine tissue, initial procedure | 103 | 93 |
| Cell examination of specimen, selective cellular enhancement technique | 76 | 71 |
| Pathology examination of specimen during surgery, first tissue block | 74 | 43 |
| Preparation of tissue for examination by removing any calcium present | 71 | 55 |
| Pathology examination of tissue using a microscope, moderately low complexity | 61 | 54 |
| Special stained specimen slides to examine tissue including interpretation and report | 33 | 16 |
| Evaluation of fine needle aspirate with interpretation and report | 20 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 12 payments worth $120 in total to this clinician.
| Phathom Pharmaceuticals, Inc. | $56.85 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $31.89 |
| Aimmune Therapeutics, Inc. | $31.71 |
| Food and Beverage | $120 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.